pargyline has been researched along with Esophageal Neoplasms in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The compounds were readily taken up by esophageal cancer cells but showed no PDT activity." | 1.39 | Synthesis and biological evaluation of Foscan® bile acid conjugates to target esophageal cancer cells. ( Gilmer, JF; Majer, F; Paszko, E; Rogers, L; Senge, MO; Sergeeva, NN, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rogers, L | 1 |
| Majer, F | 1 |
| Sergeeva, NN | 1 |
| Paszko, E | 1 |
| Gilmer, JF | 1 |
| Senge, MO | 1 |
1 other study available for pargyline and Esophageal Neoplasms
| Article | Year |
|---|---|
Synthesis and biological evaluation of Foscan® bile acid conjugates to target esophageal cancer cells.
Topics: Bile Acids and Salts; Catalysis; Cell Line, Tumor; Cell Survival; Contrast Media; Copper; Cycloaddit | 2013 |